LimFlow SA, now part of Stryker, is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation.
LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations and restore mobility for patients. This novel technology provides a new and minimally-invasive option for “no option” CLTI patients that may help them improve their lives and avoid amputation. For additional information, please visit www.limflow.com.
Shared 2 years ago
313 views
Shared 3 years ago
80 views
Shared 3 years ago
185 views
Shared 3 years ago
27 views
Shared 3 years ago
39 views
Shared 4 years ago
186 views
Shared 4 years ago
37 views
Shared 4 years ago
155 views
Shared 4 years ago
79 views
Shared 4 years ago
112 views
Shared 4 years ago
382 views
Shared 4 years ago
60 views
Shared 4 years ago
260 views
Shared 4 years ago
32 views
Shared 4 years ago
45 views
Shared 4 years ago
168 views
Shared 4 years ago
61 views
Shared 4 years ago
160 views
Shared 4 years ago
97 views
Shared 4 years ago
125 views
Shared 4 years ago
377 views
Shared 4 years ago
67 views
Shared 4 years ago
161 views
Shared 4 years ago
77 views
Shared 4 years ago
12 views
Shared 4 years ago
34 views
Shared 4 years ago
227 views
Shared 4 years ago
36 views
Shared 4 years ago
21 views
Shared 4 years ago
11 views
Shared 4 years ago
29 views
Shared 4 years ago
71 views
Shared 4 years ago
15 views
Shared 4 years ago
31 views